Pfizer Inc.

NYSE-PFE

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	1,343	1,638	1,430	1,043	1,092	1,052
Cash and Cash Equivalents
Short-Term Investments	13,641	11,611	15,887	19,434	8,860	6,048
Short-Term Investments
Restricted Short-Term Investments
Total Cash and Cash Equivalents	14,984	13,249	17,317	20,477	9,952	7,100
Accounts Receivable	14,260	12,078	11,845	11,463	14,451	11,393
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts
Total Trade Receivables	14,260	12,078	11,845	11,463	14,451	11,393
Inventories	11,468	11,669	10,852	10,851	11,721	11,447
Inventories
Other Current Assets	6,213	6,706	5,847	7,567	7,098	7,884
Current Deferred Tax Assets and Other Current Tax Assets
Current Tax Assets
Other Current Assets
Assets Held for Sale
Current Assets of Discontinued Operations and Other Assets Held for Sale
Total Current Assets	46,924	43,703	45,861	50,358	43,223	37,825
Total Current Assets
Net Property, Plant & Equipment	18,880	18,776	18,347	18,393	18,541	18,957
Property, Plant and Equipment, Net of Accumulated Depreciation
Net Intangible Assets	51,324	52,702	53,976	55,411	59,986	61,240
Identifiable Intangible Assets, Net
Goodwill	69,101	68,997	68,444	68,527	68,570	68,445
Goodwill
Long-Term Investments	2,137	2,120	2,013	2,228	10,762	11,148
Equity-Method Investments
Long-Term Investments
Other Long-Term Assets	20,365	19,798	19,387	18,479	18,395	18,577
Noncurrent Deferred Tax Assets and Other Noncurrent Tax Assets
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	208,731	206,095	208,028	213,396	219,476	216,193
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	5,024	5,166	5,240	5,633	5,314	5,106
Trade Accounts Payable
Accrued Expenses	3,036	2,447	2,607	3,838	3,383	2,566
Accrued Compensation and Related Items
Short-Term Debt	4,303	4,295	4,470	6,946	9,699	11,944
Short-Term Borrowings, Including Current Portion of Long-Term Debt
Unearned Revenue	924	1,123	1,012	1,511	2,020	2,528
Deferred Revenues
Other Current Liabilities	23,308	24,695	23,121	25,067	22,794	21,674
Dividends Payable
Income Taxes Payable
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	36,596	37,726	36,452	42,995	43,211	43,819
Total Current Liabilities
Long-Term Debt	57,409	57,502	57,639	57,405	58,002	57,506
Long-Term Debt
Other Long-Term Liabilities	21,630	21,855	23,300	24,499	25,705	26,894
Pension Benefit Obligations
Postretirement Benefit Obligations
Pension and Postretirement Benefit Obligations
Postretirement Benefit Obligations, Net
Noncurrent Deferred Tax Liabilities
Other Taxes Payable
Other Noncurrent Liabilities
Total Long-Term Liabilities	79,039	79,357	80,939	81,904	83,707	84,400
Total Liabilities	115,635	117,083	117,391	124,899	126,918	128,218
Total Liabilities

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Preferred Stock	—	—	—	—	—	—
Preferred Stock, No Par Value, at Stated Value
Common Stock	481	481	481	480	480	480
Common Stock
Treasury Stock	-115,011	-115,010	-115,008	-114,763	-114,760	-114,757
Treasury Stock, Shares at Cost
Treasury Stock
Additional Paid-in Capital	94,248	94,053	93,856	93,603	93,477	93,197
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-8,066	-8,438	-8,581	-7,842	-7,971	-7,816
Accumulated Other Comprehensive Loss
Retained Earnings	121,150	117,609	119,590	116,725	121,059	116,596
Retained Earnings
Total Common Shareholders' Equity	92,801	88,695	90,338	88,203	92,286	87,700
Total Pfizer Inc. Shareholders' Equity
Minority Interests and Other	295	317	299	294	272	275
Equity Attributable to Noncontrolling Interests
Total Shareholders' Equity	93,096	89,012	90,637	88,497	92,558	87,975
Total Equity
Total Liabilities and Shareholders' Equity	208,731	206,095	208,028	213,396	219,476	216,193
Total Liabilities and Equity